Found 0 matching trials
2157GCCC:Phase 1 of Calaspargase Pegol-mknl W/ Cytarabine and Idarubicin in Newly Dx AML PHASE1 Characterizing the regimen limiting toxicity (RLT) of chemotherapeutic drug...
Show More Status
Active Not Recruiting
Location
Greenebaum Cancer Center, University of Maryland Medical Systems
Learn More & Join Trial
Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL) PHASE2 This phase II trial tests the safety and effectiveness of giving chemothera...
Show More Location
Multiple Locations
Learn More & Join Trial
Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL) PHASE2 This is a clinical trial testing whether the addition of one of two chemoth...
Show More Location
Rady Children's Hospital
Learn More & Join Trial
Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax PHASE1 This is a phase I/II clinical trial evaluating the activity of combination ...
Show More Status
Active Not Recruiting
Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia PHASE2 This phase II/III trial is studying the side effects and how well giving da...
Show More Location
Children's Hospital of Alabama
Learn More & Join Trial
Venetoclax Basket Trial for High Risk Hematologic Malignancies PHASE1 This trial is evaluating the safety and tolerability of venetoclax with che...
Show More Location
University of California San Francisco-Benioff Children's Hospital
Learn More & Join Trial
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma PHASE3 This randomized phase III trial is studying different combination chemother...
Show More Location
Children's Hospital of Alabama
Learn More & Join Trial
Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma PHASE2 The overarching objective of this study is to use novel precision medicine ...
Show More Status
Active Not Recruiting
Location
Lucile Packard Children's Hospital Stanford University
Learn More & Join Trial
Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma PHASE2 This is a Phase II clinical trial testing the use of two antigen-directed t...
Show More Location
Novant Health Presbyterian Hemby Children's Hospital
Learn More & Join Trial
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL) PHASE2 This phase II trial studies the effect of nivolumab in combination with bli...
Show More Location
Children's Hospital of Alabama
Learn More & Join Trial